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Abstract 
Background: Transfusion of packed red blood cells (PRBCs) is associated with an increased incidence of 
nosocomial infections and an increased risk of death. The duration of storage prior to transfusion may 
influence these outcomes. Here we explore the association between the age of transfused PRBCs and 
specific patterns of inflammatory gene-expression in severely injured trauma patients.  
Methods: Severely injured trauma patients requiring ICU treatment and receiving transfusion of PRBCs 
within 24 hours of the injury were recruited. Blood samples were obtained within 2 hours of the trauma, 
at 24 hours and at 72 hours. Messenger RNA was extracted from whole blood and gene expression 
quantified using quantitative polymerase chain reaction. The median age of the units of PRBCs transfused 
to each patient was recorded. The primary outcome measure was the change in candidate gene expression 
over the initial 72hrs. 
Results: Sixty-four patients were studied. 53 (83%) patients were male and the median age was 40.5 
years (IQR 31-59). Median ISS was 31.5 (IQR 23-43) and 55 (86%) patients suffered a blunt injury. 41 
(64%) patients developed a nosocomial infection and 15 (23%) patients died before hospital discharge. 
Each patient received a median of 5 units of PRBCs (IQR 4-9.8) over the first 24hrs of hospital 
admission. The median age of the units of PRBCs transfused in each patient was 20 days (IQR 17-22). 
Older blood was associated with greater decreases in IL-12, IL-23, and RORγt (all P<0.05) gene 
expression over the initial 24hrs, greater decreases in IL-12 gene expression over 72hrs and a rise in TGF-
β gene expression over the first 72hrs. A multivariate analysis confirmed the independence of these 
associations. 
Conclusions: Increasing the duration of storage of PRBCs prior to transfusion is associated with a pattern 
of gene expression consistent with more severe immunosuppression.  
Level of Evidence: Retrospective observational study, level III. 
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Background 
The transfusion of packed red blood cells (PRBCs) has been consistently associated with 
an increased incidence of nosocomial infections and mortality.
1-3
 In the United Kingdom (UK) 
PRBCs can be stored for a maximum of 35 days prior to transfusion and in some countries for up 
to 42 days. During this time ‘storage lesions’ may develop which include morphological 
changes, acidosis, decreased 2,3 diphosphoglycerate and adenosine triphosphate, lipid 
peroxidation and apoptosis.
4
 Although the currently available evidence is composed primarily of 
retrospective, non-randomised studies, there is a suggestion that the administration of older 
PRBCs is more likely to be associated with nosocomial infections and an increased mortality.
5,6
 
The association between the duration of storage of PRBCs and poor outcome is particularly well 
described in trauma patients
7-12
 and intensive care unit (ICU) patients.
13-18
 However, the precise 
mechanism by which PRBCs stored for prolonged periods increase susceptibility to infections 
remains elusive. 
It has been repeatedly demonstrated that messenger RNA (mRNA), assayed using real-
time polymerase chain reaction (qRT-PCR), can be used to accurately quantify gene 
expression.
19-21
 By carefully selecting for analysis key cytokines and transcription factors as 
candidate genes, it is possible to make inferences about overall immune competence, and in 
particular the activity of specific immune pathways and T helper (Th) subtypes (Table 1).
22
 
Recently we described an association between PRBC administration, a pattern of inflammatory 
and immune gene expression consistent with immunosuppression and an increased incidence of 
nosocomial infection in a cohort of severely injured trauma patients admitted to an ICU.
23
  
 In this study we hypothesise that the transfusion of older PRBCs following severe trauma 
may be associated with more profound immunosuppression, thereby providing a mechanistic link 
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between longer storage times of PRBCs and the development of nosocomial infections. 
Furthermore, through the analysis of candidate gene expression, we explore which immune 
pathways are preferentially affected by the transfusion of older PRBCs.  
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Methods 
This study was conducted at The Royal London Hospital, UK, a major trauma centre 
receiving tertiary referrals from across Greater London via road and air. Care is provided by a 
designated trauma team working to well-developed trauma protocols (Supplementary Protocols 
1-3). The study was approved by the East London and City Research Ethics Committee. 
Deferred informed written consent was obtained from each patient or their next of kin. 
Patient selection 
All adult trauma patients (>15 years) who met the local criteria for trauma team 
activation were eligible for enrolment into the Activation of Coagulation and Inflammation in 
Trauma (ACIT) 2 study when research personnel were present (8am to 8pm daily). ACIT2 is a 
study prospectively evaluating aspects of coagulation and inflammation in trauma patients 
(UKCRN ID: 5637). Those patients who were transferred to the Intensive Care Unit (ICU) 
following their initial resuscitation and treatment and also received PRBCs in the 24 hours 
following the trauma were eligible for inclusion in this study.  
Exclusion criteria from ACIT2 were: arrival at hospital more than 2 hours after injury, 
transfer from another hospital, known severe liver disease, known bleeding diathesis, 
administration of >2000 ml of fluid prior to enrolment, a burn injury covering more than 5% of 
the total body surface area, infection with the human immunodeficiency virus, patients with 
neutropenia as a result of chemotherapy or patients receiving long-term treatment with 
corticosteroids.  
Transfusion in the pre-hospital (Supplementary Protocol 1) and emergency department 
environment (Supplementary Protocols 2 and 3) in this institution is guided by well-developed 
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protocols. A ‘code red’ was declared either in the pre-hospital environment or in the emergency 
department if: systolic blood pressure was <90 mmHg, there was a poor response to initial fluid 
therapy or active haemorrhage was suspected.  
All packed red cells administered are leukocyte deplete, include a standard SAGM 
additive solution and have a maximum age of 35 days.  
Data collection 
Data collected on each patient included measures of shock and tissue ischaemia (on scene 
haemodynamic variables and base excess levels) and injury severity as assessed by the injury 
severity score (ISS) (Table 2). 
The timing and constituents of any blood products administered were recorded for each 
patient during the first 24 hours of their stay. The median age of the total number of PRBCs 
transfused over the first 24 hours following injury was calculated for each patient. 
Patients were examined daily by the clinical team for the presence or absence of 
infection. Definitions of infection were agreed prospectively and based on the Center for Disease 
Control and Prevention definitions.
24
 Adjudication of infectious complications was performed in 
a blinded manner independently of the clinical team (by M.J.O’D. and H.D.T.T.). All positive 
blood cultures were reviewed in conjunction with the microbiology department and likely 
contaminants were excluded from the subsequent analysis. Survival was defined as survival to 
hospital discharge or transfer to a rehabilitation facility. In hospital death was recorded. 
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Selection of genes 
 Key constituent genes of specific immune pathways of interest (focusing on Th and Treg 
function) were selected (Table 1). 
Blood Sampling & Laboratory Techniques 
Blood samples were taken within 2 hours of the trauma, at 24 hours and at 72 hours after 
admission. At each time point blood was collected in a PAXGene
TM
 blood RNA tube 
(PreAnalytix, Hilden, Germany). Samples were analysed for their integrity and reverse 
transcribed to cDNA as previously described.
22
 Gene expression was quantified using 
quantitative RT-PCR (qRT-PCR).
22
 qRT-PCRs were performed using Taqman assays (Applied 
Biosystems, Foster City, CA) and were carried out on a 7900HT, Life Tech (Applied 
Biosystems, Foster City, CA) as previously described.
23
 Each sample was assayed in triplicate. 
Reference genes (ATP5B and GAPDH) were selected empirically from a panel of six.
25
 Relative 
quantification was calculated using the standard delta delta methodology. Results were expressed 
as a normalised ratio of candidate gene / reference gene.  
Statistical analysis 
Discrete variables are expressed as counts with percentages in parenthesis and continuous 
variables as median and interquartile range. mRNA levels were treated as continuous variables. 
All statistical tests are two-sided and a P-value of P<0.05 was considered significant. P-values in 
univariate analysis are reported without correction for multiple comparisons. Differences in 
categorical variables were calculated using a chi-squared or Fisher’s exact test as appropriate, 
and the Kruskal-Wallis test or Wilcoxon rank sum test for continuous variables. Spearman’s rank 
correlation coefficient was used to describe correlation. 
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A number of multivariate linear regression models were constructed to test whether the 
age of the blood transfused was independently associated with changes in gene expression. 
Variables descriptive of the number of units of PRBCs transfused, median age of PRBCs 
transfused over the first 24 hours following injury, shock (0 hour and 24 hour base deficit (BD)), 
severity of injury and patient age were assessed as a univariate analysis. When a P-value for a 
univariate comparison was <0.25 this variable was then added to a multivariate linear regression 
model (Table 3). Those variables failing to meet this threshold were not added to the model for 
the gene expression variable. This ensured a common adjustment model with the same 
confounders considered in each case, with inclusion based on statistical probability. Backwards 
elimination was preformed when appropriate. 
Data analysis was performed using the JMP (version 11) statistical software (SAS, Cary, 
NC, USA).
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Results 
Patients 
A total of 112 ICU patients with severe traumatic injury as an admission diagnosis were 
enrolled to ACIT2 between September 2010 and October 2012. This group has been described in 
detail previously.
23
 From this group data were available for 64 patients that received a PRBC 
transfusion within 24 hours of admission. 53 (83%) patients were male and median patient age 
was 40.5 years (IQR 31-59). Median ISS was 31.5 (IQR 23-43) and 55 (86%) patients suffered 
blunt injury. Median base deficit on admission was 4.9 mEq/L (IQR 2.4-8.8) and at 24 hours was 
0.7 mEq/L (IQR -0.7-2.6). 40 (63%) patients developed infectious complications and 15 (23%) 
patients died before hospital discharge. 
Blood transfusion 
Each patient received a median of 5 units (IQR 4-9.8) of PRBCs over the first 24 hours of 
hospital admission. Median age of the transfused PRBCs for each patient was 20 days (IQR 17-
22). Patients also received a median of 4 units (IQR 0-8) fresh frozen plasma (FFP) and 1 unit 
(IQR 0-1) of platelets.  
Univariate analysis of age of PRBCs transfused and gene expression 
  At baseline (blood sample within 2 hours of the trauma) there was an association between 
Foxp3 mRNA levels and the median age of the transfused PRBCs (r
2
=0.18, P=0.001) and also 
between GATA-3 mRNA levels and the median age of the transfused PRBCs (r
2
=0.09, P=0.03). 
No other associations were detected between gene expression at baseline and the median age of 
the PRBCs.  
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Change in gene expression was expressed by taking a ratio of both the 24 hour or the 72 
hour mRNA level to the baseline mRNA level. There was an association between decreasing IL-
12 (r
2
=0.10, P=0.03), IL-23 (r
2
=0.10, P=0.03), RORγt (r2=0.19, P=0.003), Foxp3 (r2=0.09, 
P=0.04) and GATA-3 (r
2
=0.16, P=0.007) mRNA over 24 hours and increasing age of the 
transfused PRBCs.  
There was an association between decreasing IL-12 mRNA over 72 hours (r
2
=0.20, 
P=0.01) and increasing age of the transfused PRBCs. There was also an association between 
increasing TGF-β mRNA over 72 hours (r2=0.16, P=0.03) and increasing age of the transfused 
PRBCs. 
No associations were detected between changes in IL-10, TNFα, IFN-γ, T-bet, and IL-27 
gene expression and the age of the transfused PRBCs.   
Multivariate analysis of age of PRBCs transfused and gene expression 
Multivariate linear regression models were created to test for independent associations 
between change in gene expression and the median age of transfused PRBCs in cases where a 
univariate association was detected. The selection of predictor variables is outlined in the 
methods and presented in Table 3. For decreasing IL-12 over 24 and 72 hours, decreasing RORγt 
over 24 hours and increasing TGFβ over 72 hours an independent association between change in 
gene expression and the median age of the PRBCs transfused was also present (Table 3). In the 
case of decreasing Foxp3, GATA3 and IL-23 over 24 hours the variation in gene expression 
levels was better explained by variations in patient age as opposed to variations in the median 
age of the PRBCs (Table 3). Supplementary Table 1 demonstrates the model, and model 
performance with all predictor covariates included. 
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Age of PRBCs and infections 
No associations were detected between the age of PRBCs transfused and nosocomial 
infections or in-hospital mortality. 
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Discussion 
In this study, we have assayed gene expression for a selected panel of interlinked 
cytokines and transcription factors, in order to investigate the relationship between the duration 
of storage of PRBCs prior to transfusion and the resultant immunomodulation. We found that a 
pattern of altered gene expression consistent with greater immunosuppression is associated with 
the transfusion of older PRBCs. Reduced activity in the pro-inflammatory Th1 and Th17 
pathways is evidenced by reduced gene expression of the prototypical Th1 polarising cytokine, 
IL-12, of the Th17 promoting cytokine, IL-23, and the Th17 specific transcription factor RORγt. 
The increased expression of the apoptotic and anti-inflammatory gene, TGF-β, with increasing 
age of transfused PRBCs further points to the immunosuppressive nature of the response 
observed following the transfusion of older PRBCs. 
There is now convincing evidence that the transfusion of PRBCs is independently 
associated with an excess of nosocomial infections
1
 and also with increased mortality.
26
 The 
transfusion of PRBCs stored for longer periods was originally thought to be associated with 
equivocal effects as these transfusions failed to consistently improve tissue oxygenation.
13
 
However, there is now an increasing body of evidence associating the use of older PRBCs with 
harm. Transfusion of older blood has been associated with an excess of infectious complications 
and multiple organ failure in trauma patients
7,8
 and following cardiac surgery, transfusion of 
PRBCs stored for more than 28 days has been associated with a 2.5 fold increase in pneumonic 
complications.
27,28
 Following colorectal cancer surgery transfusion of PRBCs stored beyond 20 
days more than doubled the risk of postoperative infections.
29
 In addition, the duration of storage 
of PRBCs has been independently associated with an increased risk of death in trauma patients
12
 
and following cardiac surgery.
30
 Interestingly, the mortality data suggests that older PRBCs exert 
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a detrimental effect only when transfused in larger quantities with smaller volume transfusion of 
older blood having little effect on mortality.
12
 However, these data are largely retrospective and 
consequently prone to potential bias. The results of a large randomised controlled trial 
prospectively assessing the impact of blood stored less than seven days versus a standard 
transfusion policy on mortality and nosocomial infections are awaited.
31
   
Prolonged storage of PRBCs can induce ‘storage lesions’ the clinical consequences of 
which are unclear.
3
 In particular, whether these lesions could be responsible for increasing 
susceptibility to nosocomial infections and increasing mortality remains uncertain. Our group has 
recently described an association between the transfusion of PRBCs and an excess of infectious 
complications following major trauma.
23
 Importantly, we also offered a plausible mechanism for 
the detrimental effect of PRBCs by describing a pattern of gene expression that was consistent 
with immunosuppression and was independently associated with transfusion. Here we 
demonstrate that the administration of older PRBCs exacerbates this transfusion induced 
immunosuppressed phenotype, thereby perhaps providing a mechanism for further increasing 
susceptibility to nosocomial infections.  
A reduction in IL-12, IL-23 and RORγt gene expression in association with an increase in 
TGF-β gene expression is consistent with an immunosuppressed phenotype. IL-12 is a pro-
inflammatory cytokine, produced primarily by dendritic cells and macrophages, that vigorously 
promotes the differentiation of naïve T cells into an IFN-γ producing Th1 phenotype.
32
 Th1 cells 
are an essential link between innate and adaptive immunity and are particularly important for 
effective bactericidal activity on intracellular pathogens.
33
 IL-23 is a cytokine, again produced 
primarily by dendritic cells and macrophages, that promotes differentiation to a Th17 
phenotype.
34
 RORγt is a transcription factor specific to terminally differentiated Th17 cells.
34
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Th17 cells are a branch of the adaptive immune system and appear to deal primarily with 
organisms inadequately subdued by Th1 or Th2 immunity and that seem to require a very robust 
inflammatory response.
34
 TGF-β is produced by multiple lineages of leukocytes and stromal 
cell.
35
 Although a paracrine source of TGF-β may be necessary for Th17 development
34
 this 
cytokine is better known for inducing widespread apoptosis and limiting the pro-inflammatory 
Th1 response.
35
 
 The data presented are consistent with an exaggeration of the changes in gene expression 
that we have previously observed in response to blood transfusion following severe traumatic 
injury.
23
 Although the individual biomarkers descriptive of the specific immune pathways differ 
between the two studies, the transfusion of PRBCs alone was associated with features suggestive 
of reduced activity in the Th1 and Th17 pathways
23
 whilst the additional data reported here 
suggest that transfusing older PRBCs may potentiate this response. Whilst we previously 
reported that expression of the prototypical anti-inflammatory gene, IL-10, increases in response 
to blood transfusion in trauma patients,
23
 in this cohort IL-10 gene expression was not associated 
with the age of the transfused PRBCs. It is plausible that this study was underpowered to detect 
such an association. We did however detect greater increases in another potent anti-inflammatory 
gene, TGF-β, in those patients receiving older PRBCs.         
 An association was also detected between decreasing Foxp3 and GATA-3 and the age of 
the PRBCs. These mediators are transcription factors specific to the immunosuppressive Treg cell 
response and the Th2 response respectively
36,37
 and as such these findings would not support the 
hypothesis that transfusion of older PRBCs induces a greater immunosuppressive response. 
However, an association was also detected between these variables at baseline and the age of 
PRBCs prior to transfusion. Therefore the validity of the association at 24 hours is questionable. 
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Furthermore, the multivariate analysis suggested that patient age was a more important variable 
in explaining gene expression variation in GATA3 and Foxp3 than the median age of the 
PRBCs. Whilst this may also be true for the change in IL-23 gene expression over 24 hours an 
additional marker of reduced Th17 activity, RORγt, remained independently associated with the 
transfusion of older PRBCs. 
 Although we hypothesise that the described gene expression profiles may potentially lead 
to an increased risk of subsequent infectious complications this study was not powered to detect 
such an association. These data do, however, provide a plausible mechanistic link between older 
PRBCs reducing the effectiveness of essential bactericidal functions and thereby rendering 
patients more susceptible to later infectious insults. This is an important distinction from 
suggesting that older PRBCs may directly introduce infection to the host. We previously reported 
a median time lag of 7 days between the appearance of immunosuppressive gene expression 
patterns and the detection of a bacteraemia
23
 which supports the concept that these changes are 
associated with an enhanced susceptibility to later infectious insults as opposed to representing 
an early immune response to infection. 
 This study has a number of limitations. Retrospective observational cohort studies are 
prone to systematic biases, unknown confounders and the possibility of Type 1 errors, and must 
be viewed as hypothesis generating. While the expression of a number of inflammatory 
mediators are significantly associated with the age of blood transfused, the accompanying the r
2
 
values that we present are low implying that age of blood might account for only a small 
proportion of the variation in the gene expression. However, there will be multiple influences 
present in trauma patients influencing gene expression and it would be surprising if any single 
factor, such as age of blood, had a dominant effect on the inflammatory response. Our data 
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suggests that the age of blood has a small, yet significant effect on gene expression and could 
contribute to clinical outcomes. Importantly, unlike many other factors influencing the 
inflammatory response to major trauma, it is potentially modifiable. It is possible that unknown 
confounding variables were omitted from our multivariate regression analysis despite the 
inclusion of variables descriptive of shock on admission and at 24 hours, the ISS, the volume of 
transfused PRBCs and a common adjustment model with the same confounders considered in 
each case. The inclusion of patients receiving both large and small volume transfusions may 
obscure important associations as it has been suggested that small volume transfusion of old 
blood does not adversely affect mortality.
12
 In addition to this the variability between patients 
receiving large and small volumes of PRBCs may mean that differences between the calculated 
(median) age of the blood transfused in different patients may be underestimated. Patient 
numbers preclude meaningful sub-analyses. There were some baseline associations between 
Foxp3 and GATA-3 gene expression and the age of transfused PRBCs, which introduces bias in 
the interpretation of alterations in Treg and Th2 cell types at 24 hours. It is possible that the 
observed changes in mRNA levels are explained solely, or in part, by the relative abundance of 
specific cell types collected in the whole blood samples.
38
 However, all expression data from the 
candidate genes were normalised to the reference genes ATP5B and GAPDH which were 
demonstrated to be expressed at stable levels in these patients thus minimising the effect of 
relative cellular subtype abundance in individual samples. It is also possible that residual 
allogenic leukocytes, nucleated erythrocytes, residual plasma and platelets persist even in 
leukdepleted PRBCs and these can confound the analysis through contamination. However, it 
has been demonstrated previously that the post mortem analysis of patients receiving a massive 
transfusion failed to detect any foreign DNA.
39
 It is plausible that small variations in the qRT-
 18 
PCR assay could have led to changes in the amplified signal despite having made every effort to 
standardise the process; (templates (primers and probes), mRNA (concentrations and integrity), 
the reverse transcription step and reference genes) as well as a single operator (H.D.T.T.). 
We describe an association between the transfusion of older PRBCs to severely injured patients 
and gene expression patterns suggestive of more severe immunosuppression. These data are 
hypothesis generating and provide a plausible mechanistic link between the transfusion of older 
PRBCs and an increased incidence of infectious complications.  
Author Contribution  
H.D.T.T., K.B., J.R.P., R.M.P., H.C.O., C.J.H and M.J.O’D. contributed to the study design and 
data analysis. H.D.T.T., & M.E.V. performed the data collection. H.D.T.T, & H.C.O performed 
the laboratory analysis. All authors contributed to the preparation of the manuscript. 
 
Acknowledgements 
The authors are grateful to the Centre for Trauma Sciences (C4TS) Research Fellows and staff 
for data and sample collection, Dr Anne Weaver, M.D., for allowing them to include the London 
Air Ambulance and Barts Health NHS Trust “Code Red” transfusion protocols, Mr Colin Barber 
B.Sc. for his assistance in identifying the age of the blood transfused and to Dr Charles A Mein 
D.Phil. and Miss Eva Wozniak B.Sc. for their technical assistance. 
 
 
 
 
 
 
 
 19 
References 
 
1. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, Hickner A, Rogers 
MA. Health care-associated infection after red blood cell transfusion: a systematic review 
and meta-analysis. JAMA. 2014;311:1317-1326. 
2. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a 
systematic review of the literature. Crit Care Med. 2008;36:2667-2674. 
3. Lelubre C, Vincent J-L. Red blood cell transfusion in the critically ill patient. Ann 
Intensive Care. 2011;1:43. 
4. Bennett-Guerrero E, Veldman TH, Doctor A, Telen MJ, Ortel TL, Reid TS, Mulherin 
MA, Zhu H, Buck RD, Califf RM, et al. Evolution of adverse changes in stored RBCs. 
Proc Natl Acad Sci U S A. 2007;104:17063-17068. 
5. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. 
Vox Sang. 2009;96:93-103. 
6. Lelubre C, Piagnerelli M, Vincent J-L. Association between duration of storage of 
transfused red blood cells and morbidity and mortality in adult patients: myth or reality? 
Transfusion 2009; 49:1384-1394. 
7. Zallen G, Offner PJ, Moore EE, Blackwell J, Ciesla DJ, Gabriel J, Denny C, Silliman 
CC. Age of transfused blood is an independent risk factor for postinjury multiple organ 
failure. Am J Surg. 1999;178:570-572. 
8. Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC. Increased rate of infection 
associated with transfusion of old blood after severe injury. Arch Surg. 2002; 137:711-
716. 
 20 
9. Keller ME, Jean R, LaMorte WW, Millham F, Hirsch E. Effects of age of transfused 
blood on length of stay in trauma patients: a preliminary report. J Trauma. 2002; 
53:1023-1025. 
10. Murrell Z, Haukoos JS, Putnam B, Klein SR. The effect of older blood on mortality, need 
for ICU care, and the length of ICU stay after major trauma. Am Surg. 2005;71:781-785. 
11. Leal-Noval SR, Muñoz-Gómez M, Arellano-Orden V, Marín-Caballos A, Amaya-Villar 
R, Marín A, Puppo-Moreno A, Ferrándiz-Millón C, Flores-Cordero JM, Murillo-Cabezas 
F. Impact of age of transfused blood on cerebral oxygenation in male patients with severe 
traumatic brain injury. Crit Care Med. 2008;36:1290-1296. 
12. Weinberg JA, McGwin G Jr, Griffin RL, Huynh VQ, Cherry SA 3rd, Marques MB, Reiff 
DA, Kerby JD, Rue LW 3rd. Age of transfused blood: an independent predictor of 
mortality despite universal leukoreduction. J Trauma. 2008;65:279-284. 
13. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients 
with sepsis. JAMA. 1993;269:3024-3029. 
14. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood 
transfused in septic ICU patients. Can J Anaesth. 1997;44:1256-1261. 
15. Fernandes CJ Jr, Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E. Red 
blood cell transfusion does not increase oxygen consumption in critically ill septic 
patients. Crit Care. 2001;5:362-367. 
16. Hébert PC, Chin-Yee I, Fergusson D, Blajchman M, Martineau R, Clinch J, Olberg B. A 
pilot trial evaluating the clinical effects of prolonged storage of red cells. Anesth Analg. 
2005;100:1433-1438. 
 21 
17. Taylor RW, O'Brien J, Trottier SJ, Manganaro L, Cytron M, Lesko MF, Arnzen K, 
Cappadoro C, Fu M, Plisco MS, et al. Red blood cell transfusions and nosocomial 
infections in critically ill patients. Crit Care Med. 2006;34:2302-2308. 
18. Sakr Y, Chierego M, Piagnerelli M, Verdant C, Dubois MJ, Koch M, Creteur J, Gullo A, 
Vincent JL, De Backer D. Microvascular response to red blood cell transfusion in 
patients with severe sepsis. Crit Care Med. 2007;35:1639-1644. 
19. O'Dwyer MJ, Mankan AK, Stordeur P, O'Connell B, Duggan E, White M, Kelleher DP, 
McManus R, Ryan T. The occurrence of severe sepsis and septic shock are related to 
distinct patterns of cytokine gene expression. Shock. 2006;26:544-550. 
20. O'Dwyer MJ, Mankan AK, White M, Lawless MW, Stordeur P, O'Connell B, Kelleher 
DP, McManus R, Ryan T. The human response to infection is associated with distinct 
patterns of interleukin 23 and interleukin 27 expression. Intensive Care Med. 
2008;34:683-691. 
21. White M, Martin-Loeches I, Lawless MW, O'Dwyer MJ, Doherty DG, Young V, 
Kelleher D, McManus R, Ryan T. Hospital-acquired pneumonia after lung resection 
surgery is associated with characteristic cytokine gene expression. Chest 2011;139:626-
632. 
22. Pachot A, Monneret G, Voirin N, Leissner P, Venet F, Bohé J, Payen D, Bienvenu J, 
Mougin B, Lepape A. Longitudinal study of cytokine and immune transcription factor 
mRNA expression in septic shock. Clin Immunol. 2005;114:61-69. 
23. Torrance HD, Brohi K, Pearse RM, Mein CA, Wozniak E, Prowle JR, Hinds CJ, 
OʼDwyer MJ. Association Between Gene Expression Biomarkers of Immunosuppression 
 22 
and Blood Transfusion in Severely Injured Polytrauma Patients. Ann Surg. Epub 2014 
Mar 25. 
24. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-
associated infection and criteria for specific types of infections in the acute care setting. 
Am J Infect Control. 2008;36:309-332. 
25. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of 
multiple internal control genes. Genome biol. 2002;3:RESEARCH0034. 
26. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, 
Nollet G, Peres-Bota D; ABC (Anemia and Blood Transfusion in Critical Care) 
Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 
2002;288:1499-1507. 
27. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery 
bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion. 
1999;39:701-710. 
28. Leal-Noval SR, Jara-López I, García-Garmendia JL, Marín-Niebla A, Herruzo-Avilés A, 
Camacho-Laraña P, Loscertales J. Influence of erythrocyte concentrate storage time on 
postsurgical morbidity in cardiac surgery patients. Anesthesiology. 2003;98:815-822. 
29. Mynster T, Nielsen HJ. The impact of storage time of transfused blood on postoperative 
infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer 
Study Group. Scand J Gastroenterol. 2000;35:212-217. 
 23 
30. Koch CG1, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. 
Duration of red-cell storage and complications after cardiac surgery. New Eng J Med. 
2008;358:1229-1239. 
31. Lacroix J, Hébert P, Fergusson D, Tinmouth A, Blajchman MA, Callum J, Cook D, 
Marshall JC, McIntyre L, Turgeon AF et al. Transfus Med Rev. 2011;25:197-205. 
32. Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A. 
Interleukin-12: biological properties and clinical application. Clin Cancer Res. 
2007;13:4677-4685. 
33. Kitamura N, Kaminuma O, Mori A, Hashimoto T, Kitamura F, Miyagishi M, Taira K, 
Miyatake S. Correlation between mRNA expression of Th1/Th2 cytokines and their 
specific transcription factors in human helper T-cell clones. Immunol Cell Biol. 
2005;83:536-541. 
34. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 
2009;27:485-517. 
35. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-
beta regulation of immune responses. Annu Rev Immunol. 2006;24:99-146. 
36. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 
2008;8:523-532. 
37. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for 
Th2 cytokine gene expression in CD4 T cells. Cell. 1997;89:587-596. 
38. Laudanski K, Miller-Graziano C, Xiao W, Mindrinos MN, Richards DR, De A, 
Moldawer LL, Maier RV, Bankey P, Baker HV, Brownstein BH, et al. Cell-specific 
 24 
expression and pathway analyses reveal alterations in trauma-related human T cell and 
monocyte pathways. Proc Natl Acad Sci U S A. 2006;103:15564-15569. 
39. Graham EA, Tsokos M, Rutty GN. Can post-mortem blood be used for DNA profiling 
after peri-mortem blood transfusion? Int J Legal Med. 2007;121:18-23. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 
Table 1. Selected cytokines and transcription factors and their related pathways 
Cytokine  Immune Pathway 
Contributes to anti (-) 
or pro (+) Inflammatory 
phenotype* 
 
TNFα 
 
Common end product of many innate and adaptive immune 
pathways 
 
+ 
IFN-γ Th1 effector cytokine + 
IL-12 Promotes differentiation to Th1 effector cells + 
T-bet  Transcription factor utilised by Th1 cells + 
IL-23 Promotes differentiation to Th17 phenotype + 
IL-27  Inhibits differentiation to Th17 phenotype - 
RORγT  Transcription factor utilised by Th17 cells + 
IL-10  Anti-inflammatory cytokine produced by many T cell subtypes 
and some macrophages 
- 
Foxp3 Transcription factor utilised by naturally occurring CD4+ CD25+ 
Treg cell 
- 
GATA-3 Transcription factor utilised by Th2 cells  - 
TGF-β  Induces widespread apoptosis, promotes Treg and Th17 cell 
development 
- 
*Cytokines and transcription factors will have diverse actions under different conditions and the descriptions above are primarily 
for illustrative purposes and are not exhaustive.   
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Table 2. Patient Characteristics  
 
 Median Age of Blood 
Transfused 
 
P-value 
1-20 days* 
(n=38) 
 
21-35 days* 
(n=26) 
 
Male, n (%) 
 
33 (86.8) 
 
20 (76.9) 
 
Ns 
ISS, median (IQR) 34 (25 - 48) 27 (22 - 38) Ns 
Presence of TBI, n (%) 17 (44.7) 10 (38.5) Ns 
Blunt Injury, n (%) 33 (86.8) 22 (84.6) Ns 
Penetrating Injury, n (%) 5 (13.2) 3 (11.5) Ns 
On Scene sBP, median (IQR) mmHg 112 (90 - 135) 115 (94 - 130) Ns 
Emergency Department sBP, median (IQR) mmHg 106 (80 - 139) 114 (93 - 120) Ns 
Base deficit (0hr), median (IQR) mEq/L 4.7 (2.6 - 7.5) 5.2 (2.4 - 14.1) Ns 
Lactate (0hr), median (IQR) mmol/L 2.9 (2.1 - 4.5) 3.5 (2.2 - 6.8) Ns 
pH (0hr), median (IQR) 7.29 (7.20 - 7.36) 7.29 (7.14 - 7.40) Ns 
Base deficit (24hr), median (IQR) mEq/L 0.45 (-0.7 - 1.43) 2.4 (-1.3 - 3.2) Ns 
Number of PRBCs transfused, median (IQR) u 7 (4 - 10) 5 (4 - 8) Ns 
Massive Transfusion (10 units/24hrs), n (%) 6 (16.0) 5 (19.2) Ns 
All nosocomial Infections, n (%) 24 (63.2) 16 (62.0) Ns 
Pneumonia, n (%) 13 (34.2) 9 (35.0) Ns 
BSI, n (%) 8 (21.1) 4 (15.4) Ns 
Wound Infection, n (%) 11 (29.0) 4 (15.4) Ns 
UTI, n (%) 5 (13.2) 1 (3.8) Ns 
Survival To Hospital Discharge, n (%) 30 (79.0) 19 (73.1) Ns 
Data are expressed as median (interquartile range) or n (%). ISS, Injury Severity Score; TBI, Traumatic Brain Injury; sBP, Systolic Blood 
Pressure; PRBCs, Packed Red Blood Cells; BSI, Blood stream Infection (bacteraemia or fungaemia); UTI, Urinary Track Infection.       
*Patients divided into two groups based on median age of PRBCs transfused in first 24 hours; 20 days vs. >21 days. 
 

  
Legend 
Figure 1: Graphs A-C Association between the median age of packed red blood cells (PRBCs) 
transfused in the first 24 hours following injury and the change in candidate gene expression 
over 72 hours (graphs A & B) or 24 hours (graph C). Results displayed as best-fit line (solid) and 
95% confidence interval (dashed). All results are expressed as a relative quantification ratio 
between candidate and reference genes. 
